Literature DB >> 14688111

Mice deficient in interleukin-4 (IL-4) or IL-4 receptor alpha have higher resistance to sporozoite infection with Plasmodium berghei (ANKA) than do naive wild-type mice.

Michael Saeftel1, Andreas Krueger, Sandra Arriens, Volker Heussler, Paul Racz, Bernhard Fleischer, Frank Brombacher, Achim Hoerauf.   

Abstract

BALB/c interleukin-4 (IL-4(-/-)) or IL-4 receptor-alpha (IL-4ralpha(-/-)) knockout (KO) mice were used to assess the roles of the IL-4 and IL-13 pathways during infections with the blood or liver stages of plasmodium in murine malaria. Intraperitoneal infection with the blood-stage erythrocytes of Plasmodium berghei (ANKA) resulted in 100% mortality within 24 days in BALB/c mice, as well as in the mutant mouse strains. However, when infected intravenously with the sporozoite liver stage, 60 to 80% of IL-4(-/-) and IL-4ralpha(-/-) mice survived, whereas all BALB/c mice succumbed with high parasitemia. Compared to infected BALB/c controls, the surviving KO mice showed increased NK cell numbers and expression of inducible nitric oxide synthase (iNOS) in the liver and were able to eliminate parasites early during infection. In vivo blockade of NO resulted in 100% mortality of sporozoite-infected KO mice. In vivo depletion of NK cells also resulted in 80 to 100% mortality, with a significant reduction in gamma interferon (IFN-gamma) production in the liver. These results suggest that IFN-gamma-producing NK cells are critical in host resistance against the sporozoite liver stage by inducing NO production, an effective killing effector molecule against Plasmodium. The absence of IL-4-mediated functions increases the protective innate immune mechanism identified above, which results in immunity against P. berghei infection in these mice, with no major role for IL-13.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14688111      PMCID: PMC343943          DOI: 10.1128/IAI.72.1.322-331.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  58 in total

1.  Molecular analysis of the association of HLA-B53 and resistance to severe malaria.

Authors:  A V Hill; J Elvin; A C Willis; M Aidoo; C E Allsopp; F M Gotch; X M Gao; M Takiguchi; B M Greenwood; A R Townsend
Journal:  Nature       Date:  1992-12-03       Impact factor: 49.962

2.  Protection against malaria induced by irradiated sporozoites.

Authors:  S Mellouk; F Lunel; M Sedegah; R L Beaudoin; P Druilhe
Journal:  Lancet       Date:  1990-03-24       Impact factor: 79.321

3.  Early hepatic stages of Plasmodium berghei: release of circumsporozoite protein and host cellular inflammatory response.

Authors:  Z M Khan; C Ng; J P Vanderberg
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

4.  CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria.

Authors:  M M Rodrigues; A S Cordey; G Arreaza; G Corradin; P Romero; J L Maryanski; R S Nussenzweig; F Zavala
Journal:  Int Immunol       Date:  1991-06       Impact factor: 4.823

5.  In vivo induction of the nitric oxide pathway in hepatocytes after injection with irradiated malaria sporozoites, malaria blood parasites or adjuvants.

Authors:  A K Nussler; L Rénia; V Pasquetto; F Miltgen; H Matile; D Mazier
Journal:  Eur J Immunol       Date:  1993-04       Impact factor: 5.532

6.  Safety and immunogenicity in volunteers of a recombinant Plasmodium falciparum circumsporozoite protein malaria vaccine produced in Lepidopteran cells.

Authors:  D A Herrington; G A Losonsky; G Smith; F Volvovitz; M Cochran; K Jackson; S L Hoffman; D M Gordon; M M Levine; R Edelman
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

7.  Induction of hepatic inflammatory response by Plasmodium berghei sporozoites protects BALB/c mice against challenge with Plasmodium yoelii sporozoites.

Authors:  J P Vanderberg; Z M Khan; M J Stewart
Journal:  J Parasitol       Date:  1993-10       Impact factor: 1.276

8.  Differences between IL-4R alpha-deficient and IL-4-deficient mice reveal a role for IL-13 in the regulation of Th2 responses.

Authors:  M Barner; M Mohrs; F Brombacher; M Kopf
Journal:  Curr Biol       Date:  1998-05-21       Impact factor: 10.834

9.  Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine.

Authors:  M Sedegah; T R Jones; M Kaur; R Hedstrom; P Hobart; J A Tine; S L Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

10.  Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin.

Authors:  A K Nussler; M Di Silvio; T R Billiar; R A Hoffman; D A Geller; R Selby; J Madariaga; R L Simmons
Journal:  J Exp Med       Date:  1992-07-01       Impact factor: 14.307

View more
  11 in total

Review 1.  Genetic analysis of cerebral malaria in the mouse model infected with Plasmodium berghei.

Authors:  Sabrina Torre; David Langlais; Philippe Gros
Journal:  Mamm Genome       Date:  2018-06-19       Impact factor: 2.957

Review 2.  Host resistance to malaria: using mouse models to explore the host response.

Authors:  Rhea Longley; Clare Smith; Anny Fortin; Joanne Berghout; Brendan McMorran; Gaétan Burgio; Simon Foote; Philippe Gros
Journal:  Mamm Genome       Date:  2010-11-30       Impact factor: 2.957

3.  The immunomodulatory glycan LNFPIII initiates alternative activation of murine macrophages in vivo.

Authors:  Olga Atochina; Akram A Da'dara; Mirjam Walker; Donald A Harn
Journal:  Immunology       Date:  2008-03-28       Impact factor: 7.397

4.  Piperidones with activity against Plasmodium falciparum.

Authors:  Michael Saeftel; Ramadan Salem Sarite; Tujo Njuguna; Ulrike Holzgrabe; Daniela Ulmer; Achim Hoerauf; Annette Kaiser
Journal:  Parasitol Res       Date:  2006-03-21       Impact factor: 2.289

Review 5.  Role of basophils in protective immunity to parasitic infections.

Authors:  Joerg U Eberle; David Voehringer
Journal:  Semin Immunopathol       Date:  2016-04-26       Impact factor: 9.623

6.  Invariant Valpha14 chain NKT cells promote Plasmodium berghei circumsporozoite protein-specific gamma interferon- and tumor necrosis factor alpha-producing CD8+ T cells in the liver after poxvirus vaccination of mice.

Authors:  Simone Korten; Richard J Anderson; Carolyn M Hannan; Eric G Sheu; Robert Sinden; Stephan Gadola; Masaru Taniguchi; Adrian V S Hill
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

7.  IL-25, IL-33 and TSLP receptor are not critical for development of experimental murine malaria.

Authors:  Akiko Shibui; Ayako Takamori; Mohammed E M Tolba; Aya Nambu; Eri Shimura; Sachiko Yamaguchi; Chizu Sanjoba; Hajime Suto; Katsuko Sudo; Ko Okumura; Sumio Sugano; Hideaki Morita; Hirohisa Saito; Kenji Matsumoto; Susumu Nakae
Journal:  Biochem Biophys Rep       Date:  2015-12-14

8.  IL1B, IL4R, IL12RB1 and TNF gene polymorphisms are associated with Plasmodium vivax malaria in Brazil.

Authors:  Vinicius A Sortica; Maristela G Cunha; Maria Deise O Ohnishi; Jose M Souza; Andrea K C Ribeiro-Dos-Santos; Ney P C Santos; Sídia M Callegari-Jacques; Sidney E B Santos; Mara H Hutz
Journal:  Malar J       Date:  2012-12-07       Impact factor: 2.979

Review 9.  Oxidative stress in malaria.

Authors:  Sandro Percário; Danilo R Moreira; Bruno A Q Gomes; Michelli E S Ferreira; Ana Carolina M Gonçalves; Paula S O C Laurindo; Thyago C Vilhena; Maria F Dolabela; Michael D Green
Journal:  Int J Mol Sci       Date:  2012-12-03       Impact factor: 5.923

10.  Inhibition of histamine-mediated signaling confers significant protection against severe malaria in mouse models of disease.

Authors:  Walid Beghdadi; Adeline Porcherie; Bradley S Schneider; David Dubayle; Roger Peronet; Michel Huerre; Takeshi Watanabe; Hiroshi Ohtsu; Jacques Louis; Salaheddine Mécheri
Journal:  J Exp Med       Date:  2008-01-28       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.